SCHEMBL8555124

SCHEMBL8555124

CC(C)S(=O)(=O)CCC1CCNCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
ITGB3 P05106 11/20 0.33
ITGA2B P08514 11/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
GABRA1 P14867 1/20 0.33
TSHR P16473 1/20 0.33
GABRG2 P18507 1/20 0.33
NFKB1 P19838 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRA6 Q16445 1/20 0.33
F2R P25116 1/20 0.33
GNAO1 P09471 2/20 0.33
CPN1 P15169 1/20 0.33
CPB2 Q96IY4 1/20 0.33
GNAI3 P08754 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26288606 0.86 ALDH1A1 (0.31)
SCHEMBL8557719 0.78 CHRM1 (0.34) CHRM1CHRM3ITGB3ITGA2BLMNA
SCHEMBL310513 0.78 CHRM1 (0.38) CHRM1CHRM3ITGB3ITGA2BLMNA
Hydrochloric Acid SCHEMBL310124 0.76 GNAO1 (0.38) CHRM1CHRM3ITGB3ITGA2BLMNA
SCHEMBL24008966 0.74 CHRM1 (0.36) CHRM1CHRM3ITGB3ITGA2BLMNA
SCHEMBL2169002 0.74 GABRA5 (0.46) CHRM1CHRM3ITGB3ITGA2BLMNA
SCHEMBL230908 0.74 CHRM1 (0.38) CHRM1CHRM3ITGB3ITGA2BLMNA
SCHEMBL6750241 0.73 ITGB3 (0.36) CHRM1CHRM3ITGB3ITGA2BLMNA
Hydrochloric Acid SCHEMBL20775305 0.72 CHRM1 (0.37) CHRM1CHRM3ITGB3ITGA2BLMNA
Hydrochloric Acid SCHEMBL29891111 0.72 GABRA5 (0.45) CHRM1CHRM3ITGB3ITGA2BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 EP disclosed